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REVIEW ARTICLE
Mineralocorticoid and glucocorticoid receptor-mediated control of genomic
responses to stress in the brain
Karen R. Mifsud and Johannes M. H. M. Reul
Neuro-Epigenetics Research Group, Bristol Medical School, University of Bristol, Bristol, UK
ABSTRACT
Successful coping with stressful events involves adaptive and cognitive processes in the brain that
make the individual more resilient to similar stressors in the future. Stressful events result in the secre-
tion of glucocorticoids (GCs) from the adrenal glands into the blood stream. Early work proved instru-
mental for developing the concept that these hormones act in the brain to coordinate physiological
and behavioral responses to stress through binding to two different GC-binding receptors. Once acti-
vated these receptors translocate to the nucleus where they act on target genes to facilitate (or some-
times inhibit) transcription. There are two types of receptors in the brain, the mineralocorticoid receptor
(MR), and glucocorticoid receptor (GR). This review summarizes recent work which provides new
insights regarding the genomic action of these receptors, both under baseline conditions and following
exposure to acute stress. This work is discussed alongside the extensive studies undertaken in this field
previously and new, and exciting “big data” studies which have generated a wealth of relevant data.
The consequence of these new insights will challenge existing assumptions about the role of MRs and
GRs and pave the way for the implementation of novel and improved methodologies to identify the
role these corticosteroid receptors have in stress-related behavioral adaptation.
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Introduction
The biological response to stress involves many systems (ner-
vous, endocrine, immune, etc.) co-operating together to evoke
an appropriate reaction. The threshold for the involvement of
each of these systems is specific and highly individualized
depending on the information received and the genetic, epi-
genetic, and environmental background of the individual.
A stressor is a situation which an individual perceives as
aversive and potentially harmful. In this way, stressors are
highly individualized and the impact inflicted by a specific
stressor may be different based on prior knowledge, experi-
ence, and cognitive abilities. For example, a man waving a
gun would most likely be a strong stressor for an adult but
for a baby may not constitute a stressor at all. Conversely, a
loud unexpected noise may result in a similar response in all
subjects, due to a reflex-like, innate realization that the situ-
ation could be potentially aversive or dangerous.
The stress response, namely, the collective biological and
behavioral outcomes following exposure to a stressor, is
equally individualized and has long been an area of interest
for scientists. Great progress has been made into understand-
ing the pathways involved in the stress response, especially
in responses common to most individuals, such as activation
of the sympathetic nervous system and the hypothalamic–pi-
tuitary–adrenal (HPA) axis, and the behavioral fight/freeze/
flight responses. Understanding the finer molecular responses
occurring in the brain after exposure to a stressor, and how
these link to the range of individualized behavioral responses
observed in stressed individuals remains a common goal for
researchers in the field. In pursuit of this goal, the 1st Munich
Winter Conference on Stress was held in Garmisch-
Partenkirchen (Germany) in March 2017 to bring together
both leaders and young scientists in stress research to discuss
their recent advances in the hope of inspiring collaborative
research to extend our understanding of the field. This review
relates some of these recent advances with existing literature
in order to provide a current view regarding how the brain
translates the hormonal changes induced by stress into gen-
omic responses via nuclear receptors.
Regulation of the levels of stress hormones
accessing the brain
HPA axis activation results in the release of corticotrophin-
releasing factor (CRF) from parvocellular neurons residing in
the paraventricular nucleus (PVN) of the hypothalamus, which
acts on the pituitary to induce the release of adrenocortico-
trophic hormone (ACTH) into the circulation. ACTH acts on
the adrenal cortex to stimulate the secretion of glucocorticoid
hormones (GCs) into the circulation. GCs are synthesized from
cholesterol through a series of enzymatic reactions. 11b-
hydroxysteroid dehydrogenases (11b-HSDs) regulate the bio-
logical activity of glucocorticoids, with 11b-HSD1 catalyzing
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activation of the steroid into its active forms (cortisol in
humans or corticosterone (cort) in rodents). 11b-HSD2 facili-
tate the opposite reaction converting the active forms cortisol
and cort to the inactive forms cortisone and 11-dehydrocorti-
costerone (Chapman, Holmes, & Seckl, 2013). The abundance
of 11b-HSD1 and lack of 11b-HSD2 expression in MR-positive
brain regions ensures that glucocorticoids are the primary
factor driving responses in these areas (Wyrwoll, Holmes, &
Seckl, 2011). Originally, it was thought that the adult brain
completely lacks 11b-HSD2, but indeed more recent studies
have shown low to moderate levels of 11b-HSD2 expressed
in regions such as the nucleus tractus solitarus and (other)
key regions linked to blood pressure control and sodium
appetite (Wyrwoll et al., 2011).
The HPA axis is also regulated by diurnal cues which serve
to impose a circadian rhythm to basal GC secretion. GCs act
on a wide range of tissues including the brain to induce
physiological responses. The amount of active hormone
affecting the brain is regulated by how much hormone enters
the brain (Accessibility) and how much is free to exert a bio-
logical effect (Availability).
Accessibility
Work in early 2000 looked at how GCs traversed the blood-
brain barrier (BBB) by comparing the retention of radiolabeled
steroids in wild-type versus mdr1a (multidrug resistance 1a;
abcb1a) knockout mice. The abcb1a gene encodes the multi-
drug transporter P-glycoprotein (Pgp), a key component of the
BBB playing a critical role in enforcing selective permeability of
the barrier (Schinkel, 1999). In rodents, the predominant GC is
cort, which appeared to pass freely across the BBB into the
brain. Although commonly reported that rats cannot synthe-
size cortisol due to lack of adrenal 17a-hydroxylase, there is
recent evidence that cortisol is present in rodent blood, espe-
cially in response to severe acute stress (Gong et al., 2015). In
humans, cortisol is the predominant GC but, interestingly, is
partially excluded from the brain (Karssen et al., 2001). This
may explain why humans have a higher ratio of cort to cortisol
in their brains (30%) compared with the ratio in the plasma
(5%) although the biological implication for such a difference,
if any, remains unclear (Karssen, Meijer, & De Kloet, 2005). The
freely accessible nature of the BBB to cort has since been chal-
lenged after a double knockout for both isoforms of the multi-
drug resistance gene (mdr1a and mdr1b) was developed and
revealed a significant increase in the concentration of cort in
the brain and adrenal gland of double knockout mice cf. wild-
type animals (Uhr, Holsboer, & Muller, 2002). Other studies
have shown that the permeability of the BBB to various steroids
in vivo, or of model BBB systems in vitro, can be modulated by
a number of factors including removal of adrenals by adrena-
lectomy (ADX) (Long & Holaday, 1985) and, potentially, antide-
pressants (Pariante et al., 2001).
Availability
The development of the in vivo microdialysis technique revolu-
tionized the ability of researchers to accurately monitor the
free, biologically active, GC levels present in the extracellular
fluid surrounding cells in tissues (Jasper & Engeland, 1991;
Linthorst & Reul, 2008; Linthorst, Flachskamm, Holsboer, &
Reul, 1994). Using this technique, Droste et al. (2008) showed
that cort in the extracellular fluid of the rat hippocampus fol-
lowed a circadian pattern with ultradian pulses in free cort
clearly evident over a 24 h period, a pattern that was mirrored
in the caudate putamen. Given that the caudate putamen is
not significantly involved in HPA axis regulation it is likely that
these levels of free cort throughout the brain are derived from
circulating plasma levels and not brain structure-specific mech-
anisms. A later study indeed showed a clear correlation
between the levels of free cort in the blood and the corre-
sponding levels of free cort in the periphery and the brain
(Qian, Droste, Lightman, Reul, & Linthorst, 2012).
Measurement of free cort levels in the rat brain prior to,
during and after different stressors confirmed that stress-
induced increases in total plasma cort were reflected by the
free cort levels in the hippocampus, albeit at a much lower
concentration. The duration of the stress-induced elevation in
cort depended on the type of stress, but following the return
of cort to basal levels after stress the ultradian and circadian
pulses were restored (Droste et al., 2008). Simultaneous sam-
pling of blood from the jugular vein and microdialysis of the
extracellular fluid within the hippocampus during and after
exposure of rats to forced swimming (FS) revealed a 20min
lag in the free cort hippocampal peak compared with the
peak in total plasma cort. This lag was not evident following
a subcutaneous injection of exogenous glucocorticoid, or
after a mild stressor such as exposure to the novel environ-
ment, indicating that the intensity of the stress was somehow
critical in determining the time domain of free cort exposure
in the brain (Droste et al., 2008). An explanation for this
stress-related delay was provided in a follow-up study investi-
gating the role of cort-binding globulin (CBG) after stress
(Qian et al., 2011). CBG is a transport protein which binds
GCs in the blood rendering them inactive for biological
action. FS stress caused a substantial and highly significant
release of CBG protein from the liver into the bloodstream of
rats, which did not occur after exposure of rats to a mild
stressor (novel environment) (Qian et al., 2011). The function
of this rapid release of CBG was most likely to sequester the
increase in cort secreted as a result of moderate to severe
stress, thus dampening the surge in free GC concentration
and resulting in the observed delayed increase in free cort
available throughout the body (Qian et al., 2011). The conse-
quences of delaying the rise in biologically active GC levels
may be to allow time for other stress-induced mechanisms to
become established prior to the actions of GC itself, including
the strong negative feedback GCs exert on the activated
HPA axis.
Functional role of brain GC receptors in behavioral
responses following exposure to stress
Brain mineralocorticoid and glucocorticoid receptors
In the brain, GCs exert their biological action via two types of
receptors (Reul & de Kloet, 1985). The high-affinity
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mineralocorticoid receptor (MR) is expressed predominantly
in limbic areas [i.e. hippocampus, lateral septum, central
amygdala (CeA)] whereas the low-affinity glucocorticoid
receptor (GR) is ubiquitously expressed throughout the rat
brain (Reul & de Kloet, 1985, 1986; Reul, van den Bosch, & de
Kloet, 1987). The scientific discovery of the GC receptors and
their function in the brain, especially the role of the MR, was
recently the focus of a historical review by Joels and de Kloet
(2017). Due to their very high affinity for cort, hormone bind-
ing to MRs in rats is almost saturated even under conditions
of early morning baseline HPA axis activity (Reul & de Kloet,
1985; Reul et al., 1987). These observations explain why,
under any physiological condition, MR immunoreactivity is
found in the nucleus, and hardly in the cytoplasm, of hippo-
campal principal neurons (Gesing et al., 2001). As MRs appear
to be in a constant activated state, de Kloet and Reul (1987)
proposed that these receptors exert tonic actions on brain
function. In contrast, GRs display relatively lower binding
affinity for natural GCs, which explains their low occupancy
by hormone under early morning baseline conditions in the
rat hippocampus (Reul & de Kloet, 1985; Reul et al., 1987).
Substantial occupancy of GRs is only observed after a signifi-
cant rise in circulating GCs, such as that observed after stress
or at the circadian peak of GC secretion (Reul & de Kloet,
1985; Reul, et al., 1987). The occupancy profile of GRs corre-
sponds with this receptor’s envisioned role in exerting nega-
tive feedback on enhanced HPA axis activity and in stress-
related adaptation and memory formation (Reul, 2014; Reul
et al., 1987).
Under conditions of low GC levels, GRs reside in the cyto-
plasm in a complex with heat shock protein 90 (hsp90),
FK506 binding protein 1 (FKBP51), a co-chaperone protein
which stabilizes GR in an inactive state, and other proteins.
Upon rising GC levels, GRs shed FKBP51, bind GCs and recruit
FK506 binding protein 1 (FKBP52), resulting in translocation
to the nucleus to exert biological effects at the genomic level.
Classically GRs are thought to dimerize, however, more recent
work has shown that GR can interact with DNA as a mono-
mer, dimer, tetramer or in complexes with other transcription
factors including MR, opening up additional mechanisms of
regulatory control and complexity (Nixon, Andrew, &
Chapman, 2013; Presman et al., 2016). It is presently unclear
if oligomerization occurs in the cytoplasm (Savory et al.,
2001) prior to translocation to the nucleus or at the DNA
interface (Luisi et al., 1991) where GRs bind to specific gluco-
corticoid response elements (GREs) that exist within the DNA
sequence of GC-inducible genes to elicit their transcriptional
effects (Morsink, Joels, et al., 2006; Morsink, Steenbergen,
et al., 2006). It is thought that GRs can interact at several
positions within its molecular structure to form oligomers,
both in the ligand binding domain (LBD) and DNA binding
domain (DBD) (Nixon et al., 2013). The generation of a mouse
strain with a point mutation within its DBD (GRdim) has been
reported to lack the ability for GRs to dimerize and hence
prevent GR binding to GREs in target genes (Reichardt et al.,
1998). Experiments utilizing GRdim mice highlighted the
importance of receptor dimerization in the transactivation
process, but interestingly not the transrepression of some
GC-target genes (Reichardt et al., 1998). Subsequent studies,
however, have shown that GRdim mice retain at least some
transactivation capability (Frijters et al., 2010), and replicating
the same mutation in cells resulted in some ability to GRs to
form dimers (Presman et al., 2014), therefore caution is
advised when interpreting studies using the GRdim mutation.
In addition to their function as nuclear receptors, studies
have also shown that both the MR and GR can be present in
unique membrane-bound forms with distinct roles in gluta-
matergic neurotransmission and phosphorylated cAMP
response element-binding protein (pCREB) signaling path-
ways, respectively (Karst et al., 2005; Roozendaal et al., 2010).
Although MRs and GRs show a remarkably high structural
similarity, multiple studies have identified specific properties
of the individual receptors in terms of their distribution in
the brain, molecular action and ligand specificity (Arriza,
Simerly, Swanson, & Evans, 1988; Reul & de Kloet, 1985, 1986;
Reul et al., 1987). For instance, the synthetic GC dexametha-
sone (DEX) has been shown to bind to and activate GRs,
whereas it can bind to MRs but not activate these receptors
(Rafestin-Oblin et al., 1986; Reul et al., 1987, 2000).
Researchers have exploited these differences to understand
the individual functions of these receptors in response to
challenging situations, both in intact animals and in animals
which have had their adrenals, and hence their principal
endogenous source of GCs, removed by ADX.
Removal of endogenous GCs by adrenalectomy
Early studies showed that ADX significantly impaired hippo-
campus-dependent learning and adaptive responses in
rodents exposed to several behavioral challenges, all of which
are known to activate central stress responses including HPA
axis activation (Beylin & Shors, 2003; Borrell, De Kloet,
Versteeg, & Bohus, 1983; De Kloet, De Kock, Schild, &
Veldhuis, 1988; Jefferys, Copolov, Irby, & Funder, 1983;
Jefferys & Funder, 1987; Oitzl & de Kloet, 1992; Veldhuis, De
Korte, & De Kloet, 1985). ADX blocked the stress-induced
enhancement in associative learning if trace conditioning was
performed within 1 week after surgery (Beylin & Shors, 2003).
This could not be restored by administration of a low dose of
cort or mineralocorticoids sufficient to occupy the MR, but
was recoverable if a high level of cort (sufficient to occupy
both the MR and GR) was administered 30min prior to train-
ing (Beylin & Shors, 2003; Jefferys et al., 1983). ADX did not
affect initial inhibitory avoidance training but did impair sub-
sequent inhibitory avoidance behavior if the initial training
was performed within 120 h after ADX surgery (Borrell et al.,
1983). Rats trained after 120 h post-ADX showed no deficits
in behavior when compared with SHAM-treated animals
(Borrell et al., 1983). This study highlighted the importance of
the timing of the behavioral challenge in relation to ADX and
indicates mechanisms may be acting alongside GRs and MRs
to compensate for the ongoing loss of endogenous hor-
mones after long-term ADX to recover these essential behav-
ioral processes (Borrell et al., 1983; de Kloet & Molendijk,
2016; Oitzl & de Kloet, 1992). ADX was also shown to impair
the behavioral immobility response in the FS retest, a meas-
ure of behavioral adaptation (De Kloet et al., 1988; Jefferys
et al., 1983; Reul, 2014; Veldhuis & De Kloet, 1983; Veldhuis
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et al., 1985). Later studies identified the dentate gyrus of the
hippocampus as the neural substrate of the effects of GR acti-
vation on this adaptive behavioral response (De Kloet et al.,
1988). Administration of the GR agonists DEX, RU28362, or
cort to ADX rats restored the immobility response and this
restoration was blocked by co-administration of the GR
antagonist RU486 further implicating a role for the GR in
these processes (De Kloet et al., 1988; de Kloet & Molendijk,
2016; Jefferys & Funder, 1987). Interestingly, administration of
aldosterone at a concentration to specifically activate the MR
only was unable to restore the ADX-induced deficits in the
FS-induced behavioral immobility response (De Kloet
et al., 1988).
Removing the adrenals without replacing endogenous GCs
causes extensive neuronal death in the dentate gyrus (DG) of
the rat hippocampus whilst simultaneously triggering an
increase in progenitor cell proliferation (Cameron & Gould,
1994; Sloviter et al., 1989). Over time (3–4 months) this disrup-
tion leads to degradation of the granular cell layer (Sloviter,
Dean, & Neubort, 1993; Sloviter, Sollas, Dean, & Neubort,
1993). This phenomenon relates to the fact that the hippocam-
pus is one of only a few places in the adult brain which dis-
plays constant generation of new granule neurons in the
dentate gyrus (Kempermann, Song, & Gage, 2015). The result
of this widespread cellular destruction post-ADX on learning
and memory process is less clear (Armstrong, McIntyre,
Neubort, & Sloviter, 1993). Providing ADX animals with drink-
ing water containing natural GCs (e.g. cort) protects the integ-
rity and structure of the hippocampus attenuating some of
the behavioral deficits induced by long-term ADX (Cameron &
Gould, 1994; Conrad & Roy, 1995). Activation of MRs or GRs
after ADX normalized the ADX-induced neuronal proliferation
to levels observed in intact rats. Combined activation of both
receptors, however, reduced proliferation levels in ADX ani-
mals below that of intact animals (Wong & Herbert, 2005).
Interestingly, when specific agonists were administered to
intact animals chronically over 8 days, opposite effects on
apoptosis were observed; cort, at a concentration to preferen-
tially activate the MR, reduced apoptosis, however, DEX, the
selective GR agonist, dramatically enhanced apoptosis in the
DG of these rats (Almeida et al., 2000). Chronic stress, resulting
in prolonged activation of GRs in intact animals, also leads to
enhanced cell death in the DG which can be attenuated by
administration of GR antagonist RU486 (Heine, Maslam,
Zareno, Joels, & Lucassen, 2004; Mayer et al., 2006). These find-
ings illustrate an important role for endogenous glucocorti-
coids in adult neurogenesis and in the structural morphology
of the hippocampus, although the interaction of the specific
GC receptors in these pathways remains to be fully elucidated.
Furthermore, the exact roles of MRs and GRs in the behavioral
responses observed after ADX are also still unclear.
GC pharmacology of behavioral adaptation
The use of selective corticosteroid receptor antagonists,
including the GR antagonist RU486 developed by the
pharmaceutical company Roussel Uclaf (Baulieu, 1993) pro-
vided further insight into the individual roles of the hippo-
campal MRs and GRs in adaptive behavioral responses (Oitzl
& de Kloet, 1992). It is a long-standing finding, that blocking
GR, but not MR, function results in an impaired immobility
response in rats tested 24 h after an initial FS exposure
(Bilang-Bleuel et al., 2005; Chandramohan, Droste, Arthur, &
Reul, 2008; Gutierrez-Mecinas et al., 2011; Jefferys & Funder,
1987; Veldhuis et al., 1985). Recently, we reported that the
behavioral immobility response was retained for at least
4weeks after a single FS event (Gutierrez-Mecinas et al.,
2011), strongly indicating that the consolidation of this adap-
tive behavior involves long-term neuroplasticity processes.
Our research, spanning approximately 15 years, has substan-
tially contributed to the unraveling of the molecular action of
GRs underpinning the behavioral immobility response in the
FS test. A key finding was that the consolidation of the
immobility response requires, in addition to the activation of
GRs, also the N-methyl-D-aspartate receptor (NMDAR)-acti-
vated extracellular-signal-regulated kinase-mitogen-activated
protein kinase (ERK-MAPK) pathway (Chandramohan et al.,
2008; Gutierrez-Mecinas et al., 2011), a signaling cascade well-
known for its prominent role in neuroplasticity processes
underlying learning and memory (Roberson et al., 1999).
Downstream, triggering of this pathway resulted in the acti-
vation of the nuclear kinases mitogen- and stress-activated
protein kinase 1/2 (MSK1/2) and ETS domain-containing pro-
tein (Elk-1)/p300 leading to the prompt phosphorylation and
acetylation of histone H3 molecules (H3S10p-K14ac) within
the chromatin of dentate gyrus neurons (Chandramohan
et al., 2008; Gutierrez-Mecinas et al., 2011). Collectively, the
surge in signaling activity and epigenetic modifications
induced the transcription and expression of the immediate-
early genes (IEGs) FBJ murine osteosarcoma (c-Fos) and early
growth response 1 (Egr-1) in these neurons (Chandramohan
et al., 2008; Gutierrez-Mecinas et al., 2011). The two signaling
pathways (GRs and NMDAR-ERK MAPK) were shown to be
linked as it was demonstrated that activated GR’s are
required for full nuclear kinase activity, H3S10p-K14ac forma-
tion, and IEG induction (Gutierrez-Mecinas et al., 2011).
Moreover, co-immunopreciptation studies revealed a physical
protein–protein interaction between GR, ERK1/2, and MSK1/2
following stress indicating a unique non-genomic function of
the GR in facilitating the adaptive behavioral response to
stress (Gutierrez-Mecinas et al., 2011). Recently, we found that
the induction of dentate gyrus IEGs associated with the
immobility response after FS critically involves DNA demethy-
lation of the promoter and 50-untranslated regions (50-UTR) of
these genes (Saunderson et al., 2016). Presently, it is
unknown whether GRs are involved in this epigen-
etic response.
In the Morris water maze (MWM) paradigm, blocking GR
function during the acquisition and consolidation phases of
spatial learning causes significant deficits in behavioral per-
formance (Oitzl & de Kloet, 1992; Oitzl, de Kloet, Joels,
Schmid, & Cole, 1997). These deficits were not observed if GR
blockade was restricted to the retrieval phase of testing. The
effect of blocking the MR during spatial water maze learning
resulted in a change in behavioral strategy leading to the
suggestion that the GRs are playing a role in the consolida-
tion of spatial information whereas MRs are involved in evalu-
ation and response selection (Oitzl & de Kloet, 1992). MR, but
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not GR, expression in the hippocampus was later shown to
correlate with anxiety state of individuals (Herrero, Sandi, &
Venero, 2006). Individuals displaying low levels of anxiety had
higher hippocampal MR expression when compared with
highly anxious individuals who had relatively lower MR
expression (Herrero et al., 2006). Furthermore, highly anxious
individuals showed impaired acquisition and memory forma-
tion when subjected to MWM training (Herrer, et al., 2006)
A role for GCs in determining learning strategy was sup-
ported by later studies in which Kim et al. (Kim, Lee, Han, &
Packard, 2001) investigated the effect of stress on learning in
a MWM task. Acquisition of memory between stressed and
non-stressed rats did not differ, however, rats which had
been stressed by exposure to 60 tailshocks prior to acquisi-
tion displayed an altered search strategy in the 24 h probe
test with a higher percentage of rats adopting a stimulus
(dorsal-striatal) based learning strategy as opposed to a spa-
tial (hippocampus-) based learning strategy. In the unstressed
group, all rats used a spatial learning strategy in the 24 h
probe test (Kim et al., 2001). These findings were also
observed in an analogous study on human subjects using a
similar approach (Schwabe et al., 2007). Subsequent studies
have investigated the role of MRs and GRs in mediating the
stress-induced switch in learning strategy and found that
blocking the MR, in both rodents and humans, prevented the
stress-induced preference for adopting a stimulus-response
strategy (Schwabe, Schachinger, de Kloet, & Oitzl, 2010; Vogel,
Fernandez, Joels, & Schwabe, 2016; Vogel, Klumpers, Kroes,
et al., 2015; Vogel, Klumpers, Krugers, et al., 2015). Interestingly,
blocking MRs in a non-stressful manner i.e. by administration
of the MR antagonist RU28318 in rats, resulted in a significantly
impaired spatial performance in the circular hole board
learning paradigm and also prevented mice switching to a
stimulus-response strategy when exposed to stress or follow-
ing an injection of cort leading to impaired performance
(Schwabe et al., 2010). The authors argued that by blocking MR
under conditions in which GR is activated prevents the switch
in strategy resulting in the behavioral deficits observed in
RU28318-treated mice compared with controls (Schwabe et al.,
2010). This would imply that the MR is solely responsible for
the switch in strategy as other mechanisms failed to compen-
sate when the MR was blocked by its antagonist.
Use of genetically modified rodent strains to discern GC
receptor function
The development of genetically modified receptor expression
in rodents provided another route in which to decipher GC
receptor function, however, complete loss of either the MR or
GR transcription from the early embryonic stages results in
death shortly after birth due to dehydration and respiratory
failure, respectively (Berger et al., 1998; Cole et al., 1995). In
mice only expressing one functional GR allele (GR±mice), GR
expression in the hippocampus was significantly reduced
compared with wild-type mice (Ridder et al., 2005). Despite
showing normal plasma cort levels under basal conditions,
these GR±mice had an elevated and prolonged cort
response to immobilization stress, potentially indicative of
impaired feedback onto the HPA axis. GR ±mice also showed
a significant impairment in stress coping during a three-day
learned helplessness challenge when compared with wild-
type mice. Interestingly, GR ±mice did not show any deficits
in acute challenges designed to measure locomotion and
exploration (open field and novel environment), anxiety (ele-
vated plus maze (EPM) and light/dark preference test), fear
conditioning (context or cued), or acute adaptive responses
(single FS test) (Ridder et al., 2005). In another study, trans-
genic mice expressing antisense RNA complementary to that
of the GR mRNA to reduce GR expression exhibited a similarly
elevated HPA axis response to stress, dexamethasone non-
suppression as well as cognitive impairments (Montkowski
et al., 1995; Stec, Barden, Reul, & Holsboer, 1994). These mice
spent more time in the open arms of the elevated plus maze
than wild-type animals (Montkowski et al., 1995), which is
typically interpreted as displaying reduced anxiety-like behav-
ior and was not observed in GR±mice. This interpretation,
however, needs caution as the parallel impaired performance
in the MWM is indicative of major cognitive impairments,
therefore an inability to properly assess the situation when
exposed to the elevated plus maze may also account for this
“less anxious” observation (Montkowski et al., 1995).
Furthermore, transgenic mice lacking GR throughout the
entire nervous system (Grl1LoxP mice) expressed a severe
phenotype indicative of Cushing’s syndrome (reduced size,
abnormal fat distribution, and lower bone density than con-
trols) (Tronche et al., 1999). These mice had significantly
increased plasma levels of cort under both basal conditions
and after 40min restraint stress compared with wild-type
mice. The behavioral immobility response in the 24 h-latency
FS test was reduced in Grl1LoxP mice indicative of impaired
cognition when compared with wild-type controls, and anx-
iety-like behavior in the elevated zero maze and light/dark
box was reduced (Tronche et al., 1999).
Later studies utilized regional disruption of GR in the brain
in attempts to determine function. Mice were generated with
a forebrain-specific reduction in GR expression (FBGRKO),
which became active at 3weeks of age and lead to
90–100% loss in immunoreactivity throughout the hippocam-
pus, basolateral amygdala but not the central amygdala (CeA)
and most of the cortex at 4–6 months (Boyle et al., 2005).
Diurnal HPA axis regulation was maintained in FKGRKO mice,
however, these mice showed significantly higher levels of
cort than wild-type animals at various stages of the circadian
cycle (Boyle et al., 2005; Boyle, Kolber, Vogt, Wozniak, &
Muglia, 2006; Furay, Bruestle, & Herman, 2008). These obser-
vations were made despite there being no difference in the
expression of GR in the PVN and anterior pituitary, the major
sites of negative feedback to the HPA axis, between FBGRKO
and wild-type mice indicating a role for forebrain-specific GRs
in this negative regulation of HPA function (Boyle et al.,
2005). Interestingly, although no compensatory increase in
MR mRNA/protein expression was observed in unmanipulated
FBGRKO mice compared with wild-type controls (Boyle et al.,
2005, 2006), hippocampal MR mRNA expression was
increased by handling and mild stress compared with con-
trols (Boyle et al., 2005). Restraint stress (30min), however,
caused a significant decrease in MR mRNA expression in the
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cornu ammonis 1 (CA1) and DG regions compared with con-
trols (Boyle et al., 2006).
In terms of behavior, FBGRKO mice showed reduced activ-
ity in the initial FS test and in the tail suspension test, and
sucrose preference (increased anhedonia) (Boyle et al., 2005).
Further studies into the effect of the FBGRKO on anxiety-like
behaviors revealed an increased locomotor/impulsivity
observed in the EPM and light/dark preference test (Boyle
et al., 2006), but these observations were not replicated in a
later study in which no difference in the performance of
FBGRKO and wild-type mice in the EPM was observed (Furay
et al., 2008). Inclusion of females FBGRKO mice into the ana-
lysis revealed surprising gender differences in resultant
behavior despite female subjects showing the same pattern
of brain GR disruption as male FBGRKO mice (Solomon et al.,
2012). In contrast to male FBGRKO mice, baseline cort
secretion in female FBGRKO mice did not differ from that in
wild-type mice, equally, there were no differences in stress-
induced cort secretion between FBGRKO and control females
following 30min restraint stress (Solomon et al., 2012). The
increase in behavioral immobility observed in the FS test and
the reduction in the sucrose preference test, which were
observed in male FBGRKO mice, was not apparent in female
FBGRKO mice leading to the conclusion that differences in
the central feedback response on the HPA axis between male
and female mice could explain the lack of behavioral pheno-
type in female FBGRKO mice (Solomon et al., 2012).
Meanwhile, generation of another GR mutant mouse with
GR deleted in all POMC expressing cells (GRPOMCCre) resulted
in a lack of GR immunoreactivity in the pituitary at 3 months
whilst maintaining GR expression in all other regions relevant
for HPA axis regulation including hippocampus and PVN
(Schmidt et al., 2009). Comparing the responses of GRPOMCCre
and wild-type mice exposed to chronic social defeat stress
(CSDS) revealed a resilience in GRPOMCCre mice since the
CSDS-induced increases in anxiety-like behavior and emotion-
ality and CDSD-induced decreases in exploratory behavior
were not observed in GRPOMCCre mice (Wagner et al., 2011).
Attempts to address the function of GRs in the brain from
an alternative angle resulted in the creation of a mouse strain
overexpressing GR by 78% (GRov), primarily in the forebrain
(prefrontal cortex, nucleus accumbens, bed nucleus of stria
terminalis, CeA, PVN and hippocampus) without affecting
expression in the midbrain or pituitary (Wei et al., 2004).
GRov mice displayed normal HPA axis activity, both under
basal conditions and following mild stress (EPM, 5min).
Locomotor activity did not differ significantly between GRov
and control mice; however, GRov mice spent significantly less
time and made less entries into open arms of the EPM, thus
exhibiting an enhanced anxiety response which was also
observed during the light–dark preference test (Wei et al.,
2004). Overexpression of forbrain GR increased levels of
immobility observed in the FS compared to controls (Wei
et al., 2004); the opposite response to that observed when
GR was deleted from this region (Boyle et al., 2005). A later
study from the same group investigated the consequences of
this mutation when induced at different stages of develop-
ment (Wei et al., 2012). Even if GR was only overexpressed in
early life it was capable of causing lifelong disruption of
stress vulnerability, in part by transcriptome-wide changes in
specific brain regions linked to the stress response.
Conversely, delaying overexpression of GR in this region until
mice reached adulthood did not result in the previously
observed increases in anxiety-like behavior compared with
control supporting the presence of critical periods for devel-
oping stress vulnerabilities (Wei et al., 2012).
Together these studies support a functional role for the
GR in HPA function [reviewed in Laryea, Muglia, Arnett, &
Muglia (2015)], cognition and anxiety modulation. That said,
the different genetic approaches used to create these trans-
genic strains, behavioral methodology, gender, and timing of
these manipulations appear to be confounding factors and
make widespread interpretation of these studies difficult.
Mice lacking MR (MRCaMKCre) in the forebrain were indistin-
guishable from wild-type mice in terms of life expectancy,
sensory, and motor function but did display behavioral defi-
cits, however, the nature of these deficits was hard to charac-
terize (Berger et al., 2006). A gross survey of the
hippocampus in MRCaMKCre mice showed abnormal projec-
tions between the DG and CA regions, and GR expression
was increased compared with wild-type mice throughout the
CA regions (Berger et al., 2006). Interestingly, when MR was
overexpressed in the forebrain of mice (MRov) the opposite
effect, a significant reduction in GR expression compared to
wild-type mice, was observed (Rozeboom, Akil, & Seasholtz,
2007). MRov mice also displayed reduced anxiety/increased
risk-taking behaviors in classic tests for anxiety (open field
test and EPM) (Rozeboom et al., 2007). No differential effect
was observed on basal plasma cort levels, a readout of basal
HPA activity, when these mice strains were compared with
wild-types, irrespective of whether MR was over- or under-
expressed (Berger et al., 2006; Rozeboom et al., 2007). MR
may therefore be acting to regulate GR expression and pre-
vent the development of an anxious state.
Genomic action of GC receptors under baseline
conditions and after stress
GC receptor trafficking
Brain GC receptors have been extensively characterized
already back in the 1980s and 1990s in terms of their ligand
binding properties, occupancy profile, topography, and
molecular structure. Therefore, it is surprising that it is still
largely unknown how they interact with the genome in vivo,
as well as what the consequences for gene expression, physi-
ology, and behavior are. Using sophisticated fluorescent
microscopy techniques, the intracellular dynamics of GRs, par-
ticularly their trafficking between the cytoplasm and the
nucleus, could be assessed in vitro in real time (Paakinaho
et al., 2017). This work revealed an intra-nuclear dwell time of
seconds for a single GR molecule, highlighting the highly
dynamic nature of transcription factor trafficking (Paakinaho
et al., 2017). Dwell time was significantly increased in the
presence of DEX and affected by the presence of certain
cofactors (Paakinaho et al., 2017). Studies of GR trafficking in
a GrH2 rat hepatoma cell line have shown that once released
from the chromatin unligated GR is sequestered into a
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subnuclear compartment (Yang, Liu, & DeFranco, 1997). From
this “nuclear export staging area” GR can either be reacti-
vated upon rebinding its ligand, hence bypassing travel back
through the cytoplasm, or it can be exported out of the
nucleus in an adenosine triphosphate-independent manner,
most likely through a phosphotyrosine-associated mechanism
(Yang et al., 1997). Further work and substantial advances in
technology are required to determine if these molecules fol-
low similar dynamics in vivo. Notably, the presence of GRs or
any other transcription factor in the nucleus does not neces-
sarily mean that the factor is genomically and/or transcrip-
tionally active.
Genomic action
Once it had been clarified that there are two types of GC
receptors, i.e. MRs and GRs, the quest was on to understand
their function; a quest which is still ongoing. A key role for
these receptors in genomic regulation became apparent with
numerous studies showing roles for the GR in chromatin
remodeling and transcriptional regulation by direct binding
of GC receptors to GREs (Becker, Gloss, Schmid, Strahle, &
Schutz, 1986; Burd et al., 2012; Carlstedt-Duke et al., 1988;
Chakravarti et al., 1996; Evans, Birnberg, & Rosenfeld, 1982;
Fryer & Archer, 1998; Rupprecht, Arriza, et al., 1993; Schauer,
Chalepakis, Willmann, & Beato, 1989; Scheidereit, Geisse,
Westphal, & Beato, 1983; Umesono & Evans, 1989). Mainly
using ligand-binding assays and luciferase reporter assays in
vitro, the transactivation potential of ligands as well as struc-
ture–activity relationships could be studied (Rupprecht, Arriza,
et al., 1993; Rupprecht, Reul, et al., 1993). These studies pro-
vide insight into the pharmacological profile of both GRs and
MRs and the structural requirements of the receptors for lig-
and binding, DNA binding, and transactivation. Based on this
body of work, two underlying assumptions are often made;
firstly, that the relationship between increasing GC levels and
the molecular action of GC receptors is linear, and secondly
that the occupancy of GC receptors by ligand is correlated
with the genomic action of GCs. Yet, although these studies
in vitro have been highly valuable in our understanding of
the molecular structure of GC receptors, it should be noted
that these assumptions are largely based on observations
made in vitro (e.g. by transfected receptor genes and lucifer-
ase reporter assays). Presently, it is still unclear to which
extent the observations made in cell cultures in vitro can be
transposed to the action of GCs via brain GC receptors in
vivo. We are only beginning to understand how GRs and MRs
interact with the genome in brain tissue. Moreover, until
recently, genomic interactions of MRs and GRs had only been
studied in pharmacological models (e.g. ADX and GC adminis-
tration; (Datson et al., 2011; Polman, de Kloet, & Datson,
2013)), but not under physiological conditions (e.g. stress).
The investigation of interactions between GC receptors and
target DNA has been made possible due to advances in
molecular techniques, including the chromatin immunopreci-
pitation (ChIP) technique, which can be applied on cultured
cells as well as tissues.
Recent advances
Applying ChIP on chromatin prepared from the hippocampus
of intact rats, we showed for the first time that binding of
both MRs and GRs to GREs located within or in close vicinity
of GC target genes was very low under early morning base-
line conditions but increased significantly after exposure to
acute stress or at the peak of baseline GC secretion in the
early evening (baseline PM) (Mifsud & Reul, 2016). Three well-
studied GC-inducible genes were investigated as part of this
study, namely FK506 binding protein 5 (Fkbp5), period circa-
dian clock 1 (Per1) and serum and glucocorticoid regulated
kinase 1 (Sgk1), which are involved in GR regulation, circadian
activity, and neuronal plasticity, respectively (Akiyama et al.,
1999; Anacker et al., 2013; Conway-Campbell et al., 2010;
Denny, Valentine, Reynolds, Smith, & Scammell, 2000; Polman
et al., 2012; Webster, Goya, Ge, Maiyar, & Firestone, 1993).
These genes carry GRE sites either within intronic sequences
(Fkbp5) or within their promoter region. Whilst the strong
increase in GR to GRE binding after stress (Mifsud & Reul,
2016) was expected based on earlier receptor binding studies
(Reul & de Kloet, 1985; Reul et al., 1987), the relatively low
MR binding to GREs under baseline AM conditions was sur-
prising given the high levels of MR occupancy by ligand
shown previously (Mifsud & Reul, 2016; Reul & de Kloet, 1985;
Reul et al., 1987). Previous work had shown that MRs are
highly occupied by the extremely low GC levels that circulate
in the early morning (De Kloet & Reul, 1987; Mifsud & Reul,
2016; Reul & de Kloet, 1985), and that under such conditions
these receptors are located in the nucleus of hippocampal
neurons (Gesing et al., 2001; Reul et al., 2000). Together,
these early observations indicate that although MRs are
bound by ligand and located in the nucleus in the early
morning, it appears that access and binding of the receptor
to GRE sites is tightly controlled as only relatively low levels
of binding were measured under baseline conditions (Mifsud
& Reul, 2016). At present, we can only speculate about the
molecular mechanisms enforcing the low binding of MRs to
GREs under baseline AM conditions, as outlined in Figure 1.
Possibly, access to GREs is controlled by local epigenetic
modifications of the chromatin which are subject to change
after stress or under baseline PM conditions permitting access
of MRs (and GRs) to such GREs. This is indeed the case in
human lymphoblastoid cells where it has been shown that
access of GRs to Fkbp5 GRE is controlled by the local DNA
methylation status (Klengel et al., 2013). Alternatively, steroid
receptor co-regulators can restrict or facilitate access of GC
receptors to their recognition sites, therefore, context-
dependent selectivity may be conferred by co-regulators,
forming another layer of regulatory control. Nuclear receptor
coactivator 1 (NCoA1) is a key steroid receptor coactivator
known to modulate the transcriptional response after MR and
GR activation (Grenier et al., 2004; Meijer et al., 2005; Meijer,
van der Laan, Lachize, Steenbergen, & de Kloet, 2006). Other
coregulators known to interact with GC receptors are exten-
sively reviewed elsewhere (Fuller, Yang, & Young, 2017;
Mahfouz et al., 2016). An additional mechanism explaining
the enhanced MR binding to GREs after stress may be hetero-
dimerization with GRs (see below). One may argue that these
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conclusions and concepts are based on just three GC target
genes, but our ongoing MR (and GR) ChIP studies combined
with next-generation sequencing (Seq) technology show that
this binding profile (baseline AM versus stress/baseline PM)
appears to exist in hundreds of genes across the genome.
Nevertheless, at present, the existence of genes that are
under constitutive control by MRs cannot be excluded, i.e.
such genes would be under constant regulation by MRs inter-
acting directly or indirectly with the DNA template and/or
other chromatin constituents, and presumably not through
classic GREs. Indeed, our preliminary MR ChIP-Seq indicates
that some genes present substantial binding of MRs irrespect-
ive of the physiological state (baseline AM/PM, stress) of the
animal (Mifsud, Kennedy, Salatino, Engledow, Lockstone &
Reul, unpublished).
There is further evidence for the intricate way access of GC
receptors to the genome is regulated. For instance, the rat
Fkbp5 gene contains more than one GRE site, e.g. within intron
5 there are two GREs. One GRE site, as mentioned above, read-
ily binds MRs and GRs after stress or under baseline PM condi-
tions; the other one, located just approximately 4 kb upstream
of the former one, however, does not show enhanced
binding under these conditions (Mifsud & Reul, 2016).
Our observations made in vivo correspond with previous
Fkbp5 GRE-specific findings shown in vitro (Hubler &
Scammell, 2004). Furthermore, the level of MR or GR binding
(enrichment) after stress was found to be highly gene
dependent (Mifsud & Reul, 2016). We found that, under con-
ditions of elevated circulating GCs (stress, baseline PM), the
levels of MR and GR binding to (active) GREs within Fkbp5
and Per1 was consistently higher than those at the GRE
within Sgk1. This distinction may relate to the number of
cells in the hippocampus in which particular GREs within
genes may be accessible by MRs and GRs and, as mentioned,
this regulation may be controlled by the local chromatin’s
epigenetic status, steroid co-regulator actions, and possibly
the likelihood of MR/GR heterodimer formation (Figure 1; also
see below). In addition, it is currently unknown if such control
is defined by the GRE’s nucleotide sequence and/or local
modulators of the chromatin structure mediating access and
stability of receptor-chromatin binding. These findings indi-
cate that multiple processes other than ligand-receptor bind-
ing exist, likely through distinct mechanisms, controlling both
MR and GR access to GREs within the DNA. Clearly, in GC tar-
get genes, these mechanisms are facilitated by exposure to
stress/circadian factors/elevated GC levels.
So far, the stressor mentioned in this section concerned
FS. In our recent study (Mifsud & Reul, 2016), we compared
the effects of different stressors, i.e. novelty exposure,
restraint, which, as previously shown, evoke significantly dif-
ferent increases in plasma cort levels (Qian et al., 2011). To
our surprise, after exposure to these acute stressors, the
observed MR binding levels, as well as the GR binding levels
to GREs associated with Fkbp5, Per1, and Sgk1, were largely
similar (Mifsud & Reul, 2016). Thus, although FS-evoked
plasma cort levels were approximately 5-fold higher than
those after novelty exposure, binding of MRs and GRs to
GREs was comparable. Stress-induced differences in the level
of MR/GR binding between different genes was maintained
regardless of the type of stress applied. These findings may
Figure 1. MR and GR interaction with the genome. This diagram presents an overview of the different modes of interaction of MRs and GRs with certain genes,
including Fkbp5, Sgk1, and Per1, in the hippocampus genome under baseline AM (panel A) and stress conditions (B). (A) Under baseline AM conditions (low-cort),
MRs are highly occupied and reside in the nucleus but are not able to bind or bind only weakly. This low accessibility may be due to co-regulators and/or local epi-
genetic modifications (e.g. DNA methylation, repressive histone modifications) and/or inherent low affinity of the receptor for GREs. The consequence is that such
genes present only very low transcriptional activity under baseline AM condition. (B) Under stress/baseline PM conditions (high-cort), accessibility of GREs is
enhanced (potentially resulting from expunge of inhibitory co-regulators and/or altered epigenetic status (DNA demethylation, pro-access histone modifications)).
Activated GRs form homodimers or heterodimers with MRs and bind to GREs resulting in regulation (activation or in some cases inhibition) of gene transcription.
Assisted loading mechanisms may provide MR homodimers access to GREs as well. Other genes are likely to have other mechanisms of regulation by these gluco-
corticoid receptors but these are not covered in this diagram.
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indicate that above a certain threshold of cort these GC
receptor-specific genomic responses in the hippocampus
are independent of GC levels (Mifsud & Reul, 2016).
The discrepancy between post-stress plasma cort levels and
MR/GR binding could also be due to the different nature of
the stressors (evoking differential MR/GR accessibility through
distinct epigenetic mechanisms) and/or stressor-specific influ-
ences on circulating CBG levels and their effect on the time
course of the free cort response after stress (Qian et al.,
2011). Regardless, our data demonstrate that caution should
be taken when drawing conclusions on genomic effects of
GC receptors based on circulating cort values.
GC receptor dimerization and its implications for GC
receptor-mediated gene transcription
GC receptor dimerization
As mentioned previously, one possible explanation for the
increased MR binding after exposure to stress is that MRs
may require dimerization with GRs to facilitate binding to
GREs in GC target genes. Traditionally, GR has been thought
to be the primary mediator of the genomic effects of ele-
vated cort levels after stress as it only becomes substantially
occupied after such GC levels due to its lower binding affinity
for cort compared with MR (Reul et al., 1987, 2015; Trollope,
Mifsud, Saunderson, & Reul, 2017; Zalachoras, Houtman, &
Meijer, 2013). Evidence does exist, however, showing that
MRs and GRs can form heterodimers, in addition to the
respective homodimers, in cell-free systems and in cells in
vitro (Liu, Wang, Sauter, & Pearce, 1995; Savory et al., 2001;
Trapp, Rupprecht, Castren, Reul, & Holsboer, 1994). Trapp
et al. (1994) were able to show using hormone binding
assays, electrophoretic shift assays and luciferase reporter
assays in vitro that MR:GR heterodimers were capable of
forming and exert a higher affinity to recognition sites as
well as elicit stronger gene transcriptional effects on the gen-
ome than the respective homodimers. Albeit a major contri-
bution to the molecular GC receptor field, this work,
conducted on cell cultures in vitro, did not involve ChIP ana-
lysis, thus heterodimerization could only be inferred indirectly
based mainly on (co-)transfection of MRs and/or GRs and ana-
lysis of DNA binding and transcriptional outcomes (Trapp
et al., 1994). Our recent work applied novel sequential and
tandem ChIP technologies to rat hippocampal tissues to pro-
vide strong evidence that MR:GR heterodimers are binding to
target genes in vivo (Mifsud & Reul, 2016). Furthermore, this
work showed that exposure to acute stress enhanced MR:GR
heterodimer formation at GREs in a gene-specific manner,
providing strong evidence that such heterodimers are partly
responsible for the stress-induced transcription of Fkbp5 and
Per1, but most likely not Sgk1 (Mifsud & Reul, 2016). This
technical advancement in the ChIP technology will allow the
study of the mechanisms determining the formation of MR-
GR heterodimers at certain GREs and genes as well as the sig-
nificance of such heterodimers for transcriptional regulation.
It is widely accepted that GRdim mice lack the ability to
form conventional GR homodimers due to their mutated DBD
but this region may not be required for MR:GR heterodimer
formation in vitro (Savory et al., 2001), which may explain the
lack of effect of this mutation on GC-induced Fkbp5 in GRdim
mice (Frijters et al., 2010). Interestingly, studies have shown
that, in GRdim mice in vivo, Fkbp5 gene expression retains the
ability to be upregulated (>50%) by prednisolone, a synthetic
GC that binds to both GRs and MRs (Frijters et al., 2010). This
would support our finding that MR:GR heterodimers are bind-
ing to the Fkbp5 gene under high GC conditions, i.e. after FS
stress (Mifsud & Reul, 2016).
Work performed in vitro has shown that GR is capable of
assisting binding of other transcription factors by a mechanism
referred to as “assisted loading”. Assisted loading occurs when
the binding of one receptor, in this case GR, effectively recruits
cofactors involved with the remodeling of chromatin, which
remain in place after the first receptor is released, usually
within seconds of binding (Voss et al., 2011). The remodeled
chromatin makes it easier for binding of a second receptor, in
this case MR, which on its own would not be as capable of
recruiting the cofactors required for successful binding to the
GRE. This model has been used to explain non-competitive
binding of GR and estrogen receptor (ER), as well as other
transcription factors including AP1 and pBox, to the same GRE
in cell lines in vitro (Voss et al., 2011) but no direct evidence
exists that this can occur with GRs and MRs in vivo.
Genome-wide sequencing
The dawn of next-generation sequencing (NGS) technology to
assess DNA sequences across the entire genome is revealing
the true extent of MR and GR binding to DNA under various
conditions in the rat hippocampus (Polman et al., 2013; van
Weert et al., 2017). In early GR ChIP-sequencing (Seq) studies
in ADX rats, the possible existence of two distinct populations
of GR binding sites in the hippocampus was proposed, those
that were bound by GRs across a range of cort injections
(3–3000 mg/kg) and a second set that only bound GRs if the
highest concentration of cort was administered (3000 mg/kg)
(Polman et al., 2013). More than 99.9% of significant GR bind-
ing peaks contained a GRE and motif analysis revealed that
these GREs commonly (58%) occurred together with zinc fin-
ger and BTB domain containing 3 (Zbtb3) elements. Of the 14
non-GREs containing significant GR binding peaks, all con-
tained a motif targeted by CG11181 gene product from tran-
script CG11181-RB (CUP) which has been reported to be
involved in the regulation of oocyte mRNA transcripts (Broyer,
Monfort, & Wilhelm, 2017; Polman et al., 2013); its role in the
hippocampus is unknown. Comparing GR ChIP-Seq data from
this study with MR ChIP-Seq data generated from the same
samples in parallel revealed 918 MR-exclusive sites, 475 MR-GR
overlapping sites, and 1450GR exclusive sites (van Weert et al.,
2017). All sites contained GRE-like motifs, however, an Atonal
BHLH Transcription Factor 1 (Atoh1) binding sequence was
uniquely present in close proximity to those GREs bound only
by MRs (van Weert et al., 2017). Atoh1 protein is not expressed
in the adult mouse hippocampus but subsequent analysis
both in vitro and in vivo implicated the basic helix–loop–helix
(bHLH) family member NeuroD as the likely transcription factor
interacting with this site, potentially responsible for driving
specificity for MR binding over GR at these MR exclusive sites
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(van Weert et al., 2017). ChIP-seq analysis is currently lacking
regarding the interaction of MRs and GRs with the genome
under physiological conditions like stress and circadian vari-
ation. Moreover, such data are also entirely lacking for brain
structures other than the hippocampus as well as relevant
endocrine tissues like the pituitary and adrenal gland. On a
positive note, various research groups are presently working
hard to fill these gaps in knowledge thus a wealth of whole
genome data can be expected to emerge over the com-
ing years.
Concluding remarks
This review shows how far the field has advanced, in terms of
both knowledge and development of more refined techni-
ques. Clearly, GC action upon the central nervous system is
very tightly controlled by multiple physiological, cellular, and
molecular mechanisms. Synthesis, availability, and access of
ligand and receptors and access to target DNA is regulated
through a complex network of intertwined signaling and epi-
genetic pathways and other nuclear factors (e.g. co-regulators).
This network is designed to ensure that the effects of such a
powerful, ubiquitous ligand are constrained in terms of magni-
tude and time, and specific in molecular and cellular terms.
Indeed, the advent of new technologies such as novel
ChIP protocols (Mifsud & Reul, 2016) has challenged some
existing assumptions and indicated the existence of add-
itional levels of regulatory control. Although it is still early
days, NGS studies (Polman et al., 2013; van Weert et al., 2017)
have produced an overwhelming amount of data, much of
which is still awaiting the development of the computational
pipelines and mathematical models required to reveal its full
potential. To date, NGS studies have been performed on
pharmacological models (ADX and GC administration) to
study the effects of graded doses of GCs on MR and GR bind-
ing to the genome. We are keenly anticipating the revelation
of MR and GR interaction with the genome in the context of
physiological rises in GC levels due to stress or circadian
drive. It will be interesting to see whether these data corres-
pond with those obtained in pharmacological models or indi-
cate that additional stress/circadian-related regulatory factors
are in force.
These are exciting times for GC receptor research, mainly
as a result of the developments in ChIP and NGS technolo-
gies. While the effects of stress on the brain may be becom-
ing clearer, the functional implications of such effects in
terms of physiology and behavior still remains, in part, a mys-
tery. A key challenge is an individuality in physiological and
behavioral responses which needs to be recognized in
our experimental designs and analyzes (Ardi, Albrecht,
Richter-Levin, Saha, & Richter-Levin, 2016). Such approaches
in combination with molecular analyses (MR, GR ChIP, and
NGS) may provide key insights into the genomic basis of
resilience and stress coping.
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